Abstract:This article presented the metabolic reprogramming of tumor cells to adapt to their microenvironment distinct from normal cells. And this study reviewed the driving factors of metabolic reprogramming, the specific metabolic pathway changes affected, and the related treatment options, in order to provide some suggestions for future tumor treatment. Cancer cells characterized by uncontrolled growth and proliferation require altered metabolic processes to maintain this characteristic. Metabolic reprogramming is a process mediated by various factors, including oncogenes, tumor suppressor genes, changes in growth factors, and tumor–host cell interactions, which help to meet the needs of cancer cell anabolism and promote tumor development. Metabolic reprogramming in tumor cells is dynamically variable, depending on the tumor type and microenvironment, and reprogramming involves multiple metabolic pathways. These metabolic pathways have complex mechanisms and involve the coordination of various signaling molecules, proteins, and enzymes, which increases the resistance of tumor cells to traditional antitumor therapies. With the development of cancer therapies, metabolic reprogramming has been recognized as a new therapeutic target for metabolic changes in tumor cells. Therefore, understanding how multiple metabolic pathways in cancer cells change can provide a reference for the development of new therapies for tumor treatment. Here, we systemically reviewed the metabolic changes and their alteration factors, together with the current tumor regulation treatments and other possible treatments that are still under investigation. Continuous efforts are needed to further explore the mechanism of cancer metabolism reprogramming and corresponding metabolic treatments.

Relationship between metabolic reprogramming and drug resistance in breast cancer

The Role of Aberrant Metabolism in Cancer: Insights into the Interplay Between Cell Metabolic Reprogramming, Metabolic Syndrome, and Cancer

Metabolic Reprogramming of Chemoresistant Cancer Cells and the Potential Significance of Metabolic Regulation in the Reversal of Cancer Chemoresistance

Intervention with drug resistance related to metabolism of cancer cells:advances in research

Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance

Integrating metabolic reprogramming and metabolic imaging to predict breast cancer therapeutic responses

Perspectives of Reprogramming Breast Cancer Metabolism.

Metabolic reprogramming in cancer: Mechanisms and therapeutics

The role of metabolic reprogramming in pancreatic cancer chemoresistance

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications

Targeting metabolism of breast cancer and its implications in T cell immunotherapy

Targeting Cellular Metabolism in Head and Neck Cancer Precision Medicine Era: A Promising Strategy to Overcome Therapy Resistance

The Roles of Glucose Metabolic Reprogramming in Chemo- and Radio-Resistance

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches

Novel insight into metabolic reprogrammming in cancer radioresistance: A promising therapeutic target in radiotherapy

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Altered glycolysis results in drug-resistant in clinical tumor therapy.

Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression

The Emerging Roles of Metabolism in the Crosstalk Between Breast Cancer Cells and Tumor-Associated Macrophages

Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications

Targeting cellular metabolism to improve cancer therapeutics